Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1962 1
1963 8
1964 2
1966 1
1967 2
1968 6
1969 1
1970 3
1971 2
1973 2
1974 3
1975 4
1976 2
1977 6
1978 2
1979 7
1980 4
1981 12
1982 3
1983 6
1984 4
1985 4
1986 8
1987 6
1988 18
1989 28
1990 8
1991 20
1992 25
1993 20
1994 19
1995 33
1996 26
1997 33
1998 29
1999 33
2000 40
2001 49
2002 32
2003 49
2004 48
2005 46
2006 53
2007 92
2008 113
2009 108
2010 107
2011 117
2012 135
2013 144
2014 127
2015 145
2016 171
2017 160
2018 166
2019 154
2020 211
2021 248
2022 208
2023 202
2024 89

Text availability

Article attribute

Article type

Publication date

Search Results

3,031 results

Results by year

Filters applied: . Clear all
Page 1
Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review.
Chehade M, Wright BL, Walsh S, Bailey DD, Muir AB, Klion AD, Collins MH, Davis CM, Furuta GT, Gupta S, Khoury P, Peterson KA, Jensen ET. Chehade M, et al. Among authors: walsh s. J Allergy Clin Immunol Glob. 2024 Apr 16;3(3):100260. doi: 10.1016/j.jacig.2024.100260. eCollection 2024 Aug. J Allergy Clin Immunol Glob. 2024. PMID: 38745866 Free PMC article.
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma.
Baxter MA, Spender LC, Cairns D, Walsh S, Oparka R, Porter RJ, Bray S, Skinner G, King S, Turbitt J, Collinson D, Miedzybrodzka ZH, Jellema G, Logan G, Kennedy RD, Turkington RC, McLean MH, Swinson D, Grabsch HI, Lord S, Seymour MJ, Hall PS, Petty RD. Baxter MA, et al. Among authors: walsh s. ESMO Open. 2024 May 13;9(5):103450. doi: 10.1016/j.esmoop.2024.103450. Online ahead of print. ESMO Open. 2024. PMID: 38744099
Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
Hammerslag LR, Talbert J, Slavova S, Lei F, Freeman PR, Marks KR, Fanucchi LC, Walsh SL, Lofwall MR. Hammerslag LR, et al. Among authors: walsh sl. J Subst Use Addict Treat. 2024 May 11:209391. doi: 10.1016/j.josat.2024.209391. Online ahead of print. J Subst Use Addict Treat. 2024. PMID: 38740189
Towards the Targeted Protein Degradation of PRMT1.
Martin PL, Pérez-Areales FJ, Rao SV, Walsh SJ, Carroll JS, Spring DR. Martin PL, et al. Among authors: walsh sj. ChemMedChem. 2024 May 9:e202400269. doi: 10.1002/cmdc.202400269. Online ahead of print. ChemMedChem. 2024. PMID: 38724444
3,031 results